# Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

> **NCT02156960** · PHASE4 · UNKNOWN · sponsor: **Shinshu University** · enrollment: 100 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Denosumab treatment in osteoporotic patients
- **DRUG:** Teriparatide treatment in osteoporotic patients
- **DRUG:** Denosumab and teriparatide treatment in osteoporotic patients

## Key facts

- **NCT ID:** NCT02156960
- **Lead sponsor:** Shinshu University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2015-05
- **Final completion:** 2022-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02156960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02156960, "Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02156960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*